Viewing Study NCT07193966


Ignite Creation Date: 2025-12-24 @ 4:20 PM
Ignite Modification Date: 2026-02-04 @ 3:43 AM
Study NCT ID: NCT07193966
Status: RECRUITING
Last Update Posted: 2025-09-26
First Post: 2025-09-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: NG2 and DLL3 CAR-T Cells Targeting Melanoma
Sponsor: Shenzhen Geno-Immune Medical Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None melanoma View
None CAR-T View
None chimeric antigen receptor View
None adoptive T cell transfer View
None NG2 View
None DLL3 View